Incyte INCY OPZELURA — Loss Contingency Accrual, Loss (Reversal of Loss)

Similar metrics at other companies

TSNBeef — Loss Contingency, Loss in Period

$0-100%

TSNChicken — Loss Contingency, Loss in Period

$16M—

TSNInternational — Loss Contingency, Loss in Period

$0—

TSNPork — Loss Contingency, Loss in Period

$250M0.0%

TPCCivil — Loss contingency, loss in period

$16.4M—

TSNPrepared Foods — Loss Contingency, Loss in Period

$0—

FAQ

What is Incyte's OPZELURA — loss contingency accrual, loss (reversal of loss)?

Incyte (INCY) reported OPZELURA — loss contingency accrual, loss (reversal of loss) of -$246M in Q2 2026.

What does OPZELURA — loss contingency accrual, loss (reversal of loss) mean?

This metric quantifies the financial impact of recognized losses or reversals of previously accrued losses related to legal, regulatory, or operational contingencies specific to a product line. It reflects the company's exposure to litigation, product liability, or other uncertain events that may necessitate a change in financial reserves. Investors use this to evaluate the potential financial volatility and legal risk profile associated with the commercialization of a specific therapeutic asset.